🇺🇸 FDA
Pipeline program

Cemiplimab

ACTG A5368

Phase 2 mab terminated

Quick answer

Cemiplimab for Hepatitis B Virus is a Phase 2 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Hepatitis B Virus
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials